Literature DB >> 17306896

The c-jun kinase/stress-activated pathway: regulation, function and role in human disease.

Gary L Johnson1, Kazuhiro Nakamura.   

Abstract

c-Jun N-terminal kinases (JNKs), also referred to as stress-activated kinases (SAPKs), were initially characterized by their activation in response to cell stress such as UV irradiation. JNK/SAPKs have since been characterized to be involved in proliferation, apoptosis, motility, metabolism and DNA repair. Dysregulated JNK signaling is now believed to contribute to many diseases involving neurodegeneration, chronic inflammation, birth defects, cancer and ischemia/reperfusion injury. In this review, we present our current understanding of JNK regulation and their involvement in homeostasis and dysregulation in human disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17306896      PMCID: PMC1995559          DOI: 10.1016/j.bbamcr.2006.12.009

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  100 in total

1.  Oncoprotein-mediated signalling cascade stimulates c-Jun activity by phosphorylation of serines 63 and 73.

Authors:  T Smeal; B Binetruy; D Mercola; A Grover-Bardwick; G Heidecker; U R Rapp; M Karin
Journal:  Mol Cell Biol       Date:  1992-08       Impact factor: 4.272

2.  JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain.

Authors:  B Dérijard; M Hibi; I H Wu; T Barrett; B Su; T Deng; M Karin; R J Davis
Journal:  Cell       Date:  1994-03-25       Impact factor: 41.582

Review 3.  Targeting JNK3 for the treatment of neurodegenerative disorders.

Authors:  Lynn Resnick; Myles Fennell
Journal:  Drug Discov Today       Date:  2004-11-01       Impact factor: 7.851

4.  The stress-activated protein kinase subfamily of c-Jun kinases.

Authors:  J M Kyriakis; P Banerjee; E Nikolakaki; T Dai; E A Rubie; M F Ahmad; J Avruch; J R Woodgett
Journal:  Nature       Date:  1994-05-12       Impact factor: 49.962

5.  An essential role of the JIP1 scaffold protein for JNK activation in adipose tissue.

Authors:  Anja Jaeschke; Michael P Czech; Roger J Davis
Journal:  Genes Dev       Date:  2004-08-15       Impact factor: 11.361

Review 6.  The MAPK/JNK signalling pathway offers potential therapeutic targets for the prevention of acquired deafness.

Authors:  A Zine; T R van de Water
Journal:  Curr Drug Targets CNS Neurol Disord       Date:  2004-08

7.  A divergence in the MAP kinase regulatory network defined by MEK kinase and Raf.

Authors:  C A Lange-Carter; C M Pleiman; A M Gardner; K J Blumer; G L Johnson
Journal:  Science       Date:  1993-04-16       Impact factor: 47.728

8.  Phosphorylation of c-jun mediated by MAP kinases.

Authors:  B J Pulverer; J M Kyriakis; J Avruch; E Nikolakaki; J R Woodgett
Journal:  Nature       Date:  1991-10-17       Impact factor: 49.962

9.  Inhibition of c-Jun N-terminal kinase decreases cardiomyocyte apoptosis and infarct size after myocardial ischemia and reperfusion in anaesthetized rats.

Authors:  Chiara Ferrandi; Rossana Ballerio; Pascale Gaillard; Claudio Giachetti; Sonia Carboni; Pierre-Alain Vitte; Jean-Pierre Gotteland; Rocco Cirillo
Journal:  Br J Pharmacol       Date:  2004-06-21       Impact factor: 8.739

10.  Oncogenic and transcriptional cooperation with Ha-Ras requires phosphorylation of c-Jun on serines 63 and 73.

Authors:  T Smeal; B Binetruy; D A Mercola; M Birrer; M Karin
Journal:  Nature       Date:  1991-12-12       Impact factor: 49.962

View more
  175 in total

1.  Stress-stimulated mitogen-activated protein kinases control the stability and activity of the Cdt1 DNA replication licensing factor.

Authors:  Srikripa Chandrasekaran; Ting Xu Tan; Jonathan R Hall; Jeanette Gowen Cook
Journal:  Mol Cell Biol       Date:  2011-09-19       Impact factor: 4.272

2.  Activation of the CMV-IE promoter by hyperthermia in vitro and in vivo: biphasic heat induction of cytosine deaminase suicide gene expression.

Authors:  Dennis Kobelt; Jutta Aumann; Iduna Fichtner; Ulrike Stein; Peter M Schlag; Wolfgang Walther
Journal:  Mol Biotechnol       Date:  2010-10       Impact factor: 2.695

3.  Involvement of JNK in the embryonic development and organogenesis in zebrafish.

Authors:  Yamei Xiao; Yonghua Zhou; Zhen Xiong; Lijun Zou; Minggui Jiang; Zhongwen Luo; Sheng Wen; Wenbin Liu; Shaojun Liu; Wancheng Li
Journal:  Mar Biotechnol (NY)       Date:  2013-07-25       Impact factor: 3.619

4.  Distinct functions of JNK and c-Jun in oxidant-induced hepatocyte death.

Authors:  Muhammad Amir; Kun Liu; Enpeng Zhao; Mark J Czaja
Journal:  J Cell Biochem       Date:  2012-10       Impact factor: 4.429

5.  Two hydrophobic residues can determine the specificity of mitogen-activated protein kinase docking interactions.

Authors:  A Jane Bardwell; Lee Bardwell
Journal:  J Biol Chem       Date:  2015-09-14       Impact factor: 5.157

6.  Cytoskeletal disruption activates the DLK/JNK pathway, which promotes axonal regeneration and mimics a preconditioning injury.

Authors:  Vera Valakh; Erin Frey; Elisabetta Babetto; Lauren J Walker; Aaron DiAntonio
Journal:  Neurobiol Dis       Date:  2015-02-26       Impact factor: 5.996

Review 7.  JNK: a stress-activated protein kinase therapeutic strategies and involvement in Alzheimer's and various neurodegenerative abnormalities.

Authors:  Sidharth Mehan; Harikesh Meena; Deepak Sharma; Rameshwar Sankhla
Journal:  J Mol Neurosci       Date:  2010-09-28       Impact factor: 3.444

8.  Pin1 in neuronal apoptosis.

Authors:  Esther B E Becker; Azad Bonni
Journal:  Cell Cycle       Date:  2007-06-20       Impact factor: 4.534

9.  Farnesoid X receptor antagonizes JNK signaling pathway in liver carcinogenesis by activating SOD3.

Authors:  Yan-Dong Wang; Wei-Dong Chen; Cunbao Li; Cong Guo; Yanyan Li; Hui Qi; Hailing Shen; Jing Kong; Xuecheng Long; Frank Yuan; Xichun Wang; Wendong Huang
Journal:  Mol Endocrinol       Date:  2014-12-12

Review 10.  Molecular mechanisms of lipotoxicity in nonalcoholic fatty liver disease.

Authors:  Harmeet Malhi; Gregory J Gores
Journal:  Semin Liver Dis       Date:  2008-10-27       Impact factor: 6.115

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.